MEMS in the Fight Against Covid-19

MEMS in the Fight Against Covid-19

The race against time to fight the Covid-19 pandemic has motivated a global flurry of activity and collaboration by technology companies.

On March 21, 2020, the U.S. Food and Drug Administration gave emergency authorization to California’s Cepheid to sell a new test for the rapid detection of the SARS-CoV-2 virus, which causes Covid-19. Cepheid, founded by Kurt Petersen, Allen Northrup and five others in 1996, has been well known in the MEMS community for commercializing microfluidic chip-based polymerase chain reaction (PCR) analysis machines. This is not the first time Cepheid has responded quickly to a biological threat; after the 2001 anthrax terrorist attacks in the USA, Cepheid was the first to provide rapid anthrax detection capabilities to the U.S. Postal Service, and still does today.

Read full article

Back to news list >

When you navigate our site, some cookies may be stored in or retrieved from your browser. Such information may relate to you, your preferences or your device and is primarily used to ensure that the site is operating properly. This information cannot be used to identify you directly but may be used to enhance your web experience. Since we respect your privacy, we give you the opportunity not to allow these cookies.

Close Popup
Privacy Settings saved!
Privacy settings

As you navigate through our site, certain cookies may be stored in or retrieved from your browser. This information may relate to you, your preferences or your device and is primarily used to ensure that the site functions correctly. The information does not identify you directly, but may help you benefit from an enhanced Web experience. Because we respect your privacy, we give you the opportunity not to allow these cookies.


Google Analytics
We track anonymized user information to improve our website.
  • _ga
  • _gid
  • _gat

Decline
Save
Accept